Arkis BioSciences

Arkis BioSciences, founded in 2011, is an innovative biotechnology company that specializes in producing and distributing advanced catheters and minimally invasive tools for neurosurgery. With the slogan "Innovative solutions for neurosurgery, enhancing precision and patient outcomes," the company is focused on enhancing precision and improving patient outcomes in neurosurgical procedures. Their unique catheters, featuring Endexo, aim to minimize catheter-related complications, while their instruments are crafted for reduced invasiveness in various neurosurgical procedures. This comprehensive suite of products empowers healthcare professionals to potentially minimize surgical trauma, reduce operation time, and lower the risk of treatment complications. Arkis BioSciences recently secured a $795.00K Convertible Note investment on 26 February 2019 from Innova Memphis and Lighthouse Funds. This investment signifies a vote of confidence in the company's innovative approach to neurosurgery and its potential to make a meaningful impact in the healthcare industry. With a focus on biotechnology, health care, and medical devices, Arkis BioSciences is poised to continue its growth trajectory and further revolutionize neurosurgical practices.